Calls for Proposals FY 2023 [1st Alignment Call] Advanced International Collaborative Research Program - Adopting Sustainable Partnerships for an Innovative Research Ecosystem(ASPIRE)
Change log
14th September, 2023 Participating funding agencies (ARC/Australia)Notes added.
8th August, 2023 Participating funding agencies (ARC/Australia、NIMH/United States of America) added.
7th August, 2023 Participating funding agencies (NIAMS/United States of America) added.
28th July, 2023 Participating funding agencies (NIA/United States of America、NICHD/United States of America) added.
26th July, 2023 Q&A updated.
24th July, 2023 Interview dates have been set.
19th July, 2023 Participating funding agencies (NIDDK/United States of America) added.
18th July, 2023 UKRI, including MRC, was added to the participating funding agencies.
12th July, 2023 Please note that there is no item "2" "8" in the proposal form.
11th July, 2023 Participating funding agencies (Cancer Research UK/United Kingdom) added.
10th July, 2023 Participating funding agencies (Wellcom Trust/United Kingdom) added.
7th July, 2023 Participating funding agencies (ANR/France、STINT/Sweden) added.
29th June, 2023 Participating funding agencies (TIPS/Canada、Vinnova/Sweden) added.
14th June, 2023 Participating funding agencies (SRC/Sweden) added.
Outline
Status of Grants/Funding Opportunities | Grants/Funding Opportunities |
---|---|
R&D phase | Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study |
Key Fields | Project for Seeds Development and Research Base |
Submission Deadline | 08/08/23 Tue (1)Preproposal:12:00 noon, Tuesday, July 11, 2023(Japan Standard Time) Submit via e-mail for Japan-based applicants (2)Full proposal:12:00 noon, Tuesday, August 8, 2023(Japan Standard Time) Submit via e-Rad for Japan-based applicants |
Contact |
|
Public offering content
Research Type | Research Area | Project size (excluding indirect costs) |
Research period | Expected number of projects to be selected |
---|---|---|---|---|
ASPIRE-A | Cellular Structure and Function | Up to total 380 million yen per project※1 (for 5-year research) |
FY2023 to FY2028 (Max. 5 years) |
0-3 project(s) |
Complex Systems of Living Organisms | ||||
Human Life Stages | ||||
ASPIRE-B | Cellular Structure and Function | Up to total 115 million yen per project※1 (for 5-year research) |
FY2023 to FY2028 (3-5 years) |
0-4 project(s) |
Complex Systems of Living Organisms | ||||
Human Life Stages |
※1 Total budget for the entire research period
Research areas
1.Cellular Structure and FunctionThis research area focuses on cellular structure and function. As imaging and analysis technologies have advanced, various phenomena have been observed, such as the dynamic state of organelles in cells and the liquid-liquid phase separation of proteins and nucleic acids. This research area also covers protein structure analysis and prediction using cryo-EM and AI, which can be used in drug design, for example.
2.Complex Systems of Living Organisms
Our understanding of complex systems, including cell-to-cell and tissue-to-tissue interactions, pathogen-host interactions, and even human-human social relationships, is being enhanced by non-invasive biomedical measurement methods and AI technologies for analyzing large-scale complexity. This research area aims to clarify the mechanisms of maintenance and breakdown of biological functions caused by such interactions. As a result, new medical innovations will be developed for controlling them.
3. Human Life Stages
In this research area, research based on life stages such as human development, maturation, and aging will be studied. It also includes research on phenomena specific to each life stage. Research using age cohorts and birth cohorts, as well as experimental animals and cultured cells that model human life stages, are also actively studied. Within this research area, aging research and healthy longevity research are particularly important issues in a super-aging society and are research themes of global interest.
Participating funding agencies and researchers in counterpart team
(1)Participating funding agencies (FA)
Country※2 | Partner funding agency | Type of participation | Notes |
---|---|---|---|
Australia | Australian Research Council(ARC) | Existing grant | Please contact arc-international”AT”arc.gov.au※3 for more information. |
National Health and Medical Research Council(NHMRC) | Existing grant | NHMRC-funded researchers interested in this opportunity should contact the NHMRC Research Help Centre help”AT”nhmrc.gov.au※3 for further information. |
|
Canada | Canadian Institutes of Health Research(CIHR) | Existing grant | Please contact CIHR if you have any questions or require further information. |
Tri-agency Institutional Programs Secretariat(TIPS) | Existing grant | Targeted programs:Canada First Research Excellence Fund(CFREF)/ Fonds d’excellence en recherche Apogée Canada, Canada Excellence Research Chairs(CERC)/ Chaires d’excellence en recherche du Canada Please contact TIPS if you have any questions or require further information. |
|
France | French National Research Agency(ANR) | Existing grant | |
French National Cancer Institute(INCa) | Existing grant | ||
Germany | German Research Foundation(DFG) | Existing grant | Contact point for German researchers interested in this activity: Raoul Wagner raoul.wagner“AT”dfg.de※3 |
Sweden |
Vetenskapsrådet - Swedish Research Council(SRC) |
Existing grant | |
Swedish Foundation for International Cooperation in Research and Higher Education(STINT) | Existing grant | Swedish researchers partnering with Japanese team should contact STINT upon application | |
Vinnova | Existing grant + chance of additional grant | Swedish researchers partnering with Japanese team should contact Vinnova upon application. | |
Switzerland | Swiss National Science Foundation(SNSF) | Existing grant + chance of additional grant | Researchers funded by the SNSF who are interested in collaborating with Japanese partners under this call can contact International Cooperation SNSF (international“AT”snf.ch)※3 Collaboration with Japan: AMED & JST “Alignment Calls” (snf.ch) |
United Kingdom |
Cancer Research UK | Existing grant | |
National Institute for Health and Care Research(NIHR) | Existing grant | Information about all NIHR funded awards can be found at fundingawards.nihr.ac.uk. UK researchers partnering on an application with a Japanese team should inform the NIHR by emailing international”AT”nihr.ac.uk※3 | |
UK Research and Innovation(UKRI) | Existing grant | Applicants do not need to contact MRC, however, if they wish to discuss the application or have queries, contact international”AT”mrc.ukri.org※3 | |
Wellcome Trust | Existing grant | Researchers do not need to contact Wellcome before becoming part of a collaboration, but must ensure any collaboration does not put their Wellcome-funded research outcomes at risk. If you have any queries, please contact fundingsupport”AT”wellcome.org※3 | |
United States of America | National Institutes of Health(NIH)/ National Cancer Institute(NCI) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. |
National Institutes of Health(NIH)/ National Institute on Aging(NIA) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Institutes of Health(NIH)/ National Institute of Allergy and Infectious Diseases(NIAID) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Institutes of Health(NIH)/ National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Institutes of Health(NIH)/ National Institute of Child Health and Human Development(NICHD) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Institutes of Health(NIH)/National Institute of Diabetes and Digestive and Kidney Diseases(NIDDK) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Institutes of Health(NIH)/ National Institute of Mental Health(NIMH) | Existing grant | It is encouraged that NIH-awarded investigators inform their POs upon ASPIRE application. | |
National Science Foundation(NSF) | Existing grant | It is encouraged that NSF-awarded investigators inform their POs upon ASPIRE application. |
(As of August 8, 2023)
※2 Country: Alphabetical order
※3 Replace “AT” with @
Counterpart researchers need to meet either criteria i)or ii):
- i)already be receiving research support from an eligible funding agency in their country; or
ii)are currently applying for research support from an eligible funding agency in their country, with the outcome known by no later than the end of August 2023.
A prior agreement must be in place regarding the implementation of joint research and the acceptance of the traveling researcher
between Japan and counterpart teams.
Note:
- Application will not be accepted if the partner country researcher has not received a grant for the project from their FA, or if their proposal under evaluation has been rejected.
- If you would like to collaborate with a researcher who receives support from a funding agency in Europe and North America other than the agencies listed above, please contact amed-aspire“AT”amed.go.jp(Replace “AT” with @)in advance. AMED may or may not be able to provide support through this program depending on the funding agency in question.
Eligibility
Japan-based applicants
Eligible applicants for this program are Principal Investigators who are affiliated with a research institution in Japan for the duration of the R&D period and who are responsible for formulating R&D implementation plans and compiling results with regard to the R&D proposal for which they have applied.
A researcher who does not belong to a specific research institute in Japan or who belongs to a research institute outside Japan may also apply as a Principal Investigator. However, he/she must belong to a research institute in Japan by the date of the contract conclusion or February 1, 2024, and must be able to conduct the research for the entire R&D period. Otherwise, the selection will be cancelled in principle.
Program summary
-
Adopting Sustainable Partnerships for Innovative Research Ecosystem (ASPIRE) aims to provide sufficient funds for large-scale collaborative joint research projects in cutting-edge fields, to be conducted at the initiative of the Japanese government in collaboration with advanced countries with high standards of science and technology.
-
Under the cooperation of funding agencies in between Japan and partner country, this new fund will support international joint research strategically by enabling flexibility to set the research budget and support period.
-
Through this international research collaboration, Japanese researchers will be encouraged to join the world’s leading scientific community. The exchange and connection of excellent young researchers from Japan and partner countries will also be strengthened. This will promote international talent mobility and circulation, and contribute to long-term collaborative networks.
-
Proposal solicitation, evaluation, adoption, support, etc. in this program will be conducted by the Japan Agency for Medical Research and Development (AMED) and the Japan Science and Technology Agency (JST), and AMED will support research projects in the field of “Healthcare”.
Program Details
Solicitation Period
Submit via e-mail for Japan-based applicants
(2)Full proposal:12:00 noon, Tuesday, August 8, 2023(Japan Standard Time)
Submit via e-Rad for Japan-based applicants
Interview Schedule
November 17 or 18, 2023(tentative)
Candidate proposals that are selected for interview will be notified by e-mail to the Principal Investigator of the proposal at least one week prior to the interview. If the proposal is not eligible for an interview, or if the interview itself will not be conducted, we will not contact you. Please wait until you are notified of the acceptance or rejection of your proposal.
Public invitation briefing
The event has ended.
Date:13:00 – 15:00, June 15, 2023 (Japan Standard Time)
※ Click here for the materials
How to Apply
Applicants must submit both(1)Preproposal documents(via email)and(2)Full proposal documents (via e-Rad) .
Applications will not be accepted if not completed within the respective submission deadlines.
(1)Preproposal documents (via email)
Submission deadline:12:00 noon, July 11, 2023 (Japan Standard Time)
Preproposal documents including Annex 1 (Letter of Intent) must be submitted by email to the Call Secretariat. If the preproposal documents are not submitted by the deadline, application to the Call will not be accepted.
Submit to:amed-aspire“AT”amed.go.jp
(Replace “AT” with @)
(2)Full proposal documents (via e-Rad)
Submission deadline:12:00 noon, August 8, 2023 (Japan Standard Time)
Please note that there is no item "2" "8" in the proposal form.
Full proposal documents must be submitted on the Cross-ministerial Research and Development Management System (e-Rad).
Applicants
Reference
(Japanese language only)
- Application Guideline
- Preproposal Form
- Letter of Intent
- Full Proposal Form
- Human Whole Genome Sequence Analysis Protocol form (if applicable)
Reference Information
06/06/23
Last updated 09/14/23